Prognostic value of serum tumor antigen CA19-9 after curative resection of colorectal cancer

IJ Park, GS Choi, SH Jun - Anticancer research, 2009 - ar.iiarjournals.org
Background: CA19-9 was evaluated as a prognostic marker for colorectal cancer and
whether it could be helpful in addition to surveillance using CEA was also tested. Materials …

Preoperative serum level of CA19-9 predicts recurrence after curative surgery in node-negative colorectal cancer patients.

T Nakagoe, T Sawai, T Tsuji, M Jibiki… - Hepato …, 2003 - europepmc.org
Results Twenty-seven patients (18.6%) were included in the high group for CA19-9 antigen,
11 (7.6%) for SLX, 13 (9.0%) for STN, and 51 (35.2%) for CEA. The median follow-up was …

Does serum CA19-9 play a practical role in the management of patients with colorectal cancer?

S Morita, T Nomura, Y Fukushima, T Morimoto… - Diseases of the colon & …, 2004 - Springer
PURPOSE: CA19-9 is often used in combination with carcinoembryonic antigen to manage
patients with colorectal cancer, even though there is insufficient evidence to support this use …

The role of periodic serum CA19-9 test in surveillance after colorectal cancer surgery

R Okamura, S Hasegawa, K Hida, N Hoshino… - International journal of …, 2017 - Springer
Background The serum carcinoembryonic antigen (CEA) test is mainly used for
postoperative surveillance of colorectal cancer patients in Western and Japanese …

Clinical significance of CEA and CA19-9 in postoperative follow-up of colorectal cancer

T Yakabe, Y Nakafusa, K Sumi, A Miyoshi… - Annals of surgical …, 2010 - Springer
Background We evaluated the efficiency of CEA and CA19-9 as tools for diagnosing
recurrence in the postoperative surveillance of colorectal cancer. Materials and Methods A …

[HTML][HTML] Preoperative serum CA19-9 should be routinely measured in the colorectal patients with preoperative normal serum CEA: A multicenter retrospective cohort …

Z Li, H Zhu, X Pang, Y Mao, X Yi, C Li, M Lei, X Cheng… - BMC cancer, 2022 - Springer
Objective Whether preoperative serum carbohydrate antigen 19–9 (CA19-9) is an
independent prognostic factor and there are interactions of serum CA19-9 with …

The Prognostic Value of Preoperative Serum CEA and CA19-9 Values in Stage I-III Colorectal Cancer.

RF Wang, BR Song, JJ Peng, GX Cai, FQ Liu… - Hepato …, 2014 - europepmc.org
Results In univariate analysis, differentiation (P< 0.001), depth of invasion (P< 0.001),
number of lymph node metastases (P< 0.001), and elevated levels of CEA (P< 0.001) and …

CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer.

WS Wang, JK Lin, TJ Chiou, JH Liu, FS Fan… - Hepato …, 2002 - europepmc.org
BACKGROUND/AIMS: Colorectal cancer is the third leading cause of cancer-related
mortality in Taiwan. We became interested in searching for the factors predictive of survival …

Significance of CEA and CA19-9 combination as a prognostic indicator and for recurrence monitoring in patients with stage II colorectal cancer

M Shibutani, K Maeda, H Nagahara, H Ohtani… - Anticancer …, 2014 - ar.iiarjournals.org
Background: The purpose of this study was to evaluate the significance of the combination of
the carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) levels as a …

Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?

CC Chen, SH Yang, JK Lin, TC Lin, WS Chen… - Journal of surgical …, 2005 - Elsevier
BACKGROUND: Carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9)
are the most common tumor markers for colorectal cancer. The aim of this study was to …